Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

The overall goal of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) is to validate biomarkers for Alzheimer’s disease (AD) clinical trials. ADNI-3, which began on August 1, 2016, is a 5-year renewal of the current ADNI-2 study. Read & Research Alzheimer’s More

Leave a Reply